BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230405T120000
DTEND;TZID=America/New_York:20230405T133000
DTSTAMP:20260610T181841
CREATED:20230329T190608Z
LAST-MODIFIED:20230329T190608Z
UID:3215-1680696000-1680701400@www.ctnnortheastnode.org
SUMMARY:Treatment Considerations in the Age of Fentanyl
DESCRIPTION:Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems\, treatment providers\, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. \nSpeakers: – Kathryn Cates-Wessel\, CEO\, American Academy of Addiction Psychiatry – John J. Mariani\, MD\, Associate Professor of Clinical Psychiatry Division on Substance Use Disorders\, Columbia University – Tisha Wiley\, PhD\, Branch Chief\, Associate Director for Justice Systems\, NIDA – Jessica Hulsey\, Executive Director\, Addiction Policy Forum. \nPresenters will discuss practical clinical practice-based guidance on treating opioid use disorder in the age of fentanyl\, the use of medications for opioid use disorder (MOUD) in the treatment of individuals using fentanyl\, and other considerations and challenges. This free webinar is sponsored by the Addiction Policy Forum\, the Justice Community Opioid Innovation Network (JCOIN) at the National Institute on Drug Abuse (NIDA)\, the American Academy of Addiction Psychiatry (AAAP)\, and the Providers Clinical Support System (PCSS). \n This webinar is part of the JCOIN Speaker Series. Led by the National Institute on Drug Abuse (NIDA) and funded by the NIH HEAL Initiative®\, JCOIN is a groundbreaking initiative designed to advance scientific knowledge on effective policies\, practices\, and interventions to address the opioid crisis among justice-involved individuals\, by partnering researchers with justice agencies and community health programs. \nRSVP
URL:https://www.ctnnortheastnode.org/event/treatment-considerations-in-the-age-of-fentanyl/
CATEGORIES:Other Related
ORGANIZER;CN="Addiction Policy Forum":MAILTO:info@addictionpolicy.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230406T150000
DTEND;TZID=America/New_York:20230406T160000
DTSTAMP:20260610T181841
CREATED:20230403T224440Z
LAST-MODIFIED:20230403T224440Z
UID:3218-1680793200-1680796800@www.ctnnortheastnode.org
SUMMARY:Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain\, Opioid Misuse\, and Opioid Use Disorder
DESCRIPTION:Register Now \n  \nPresenter: Eric Garland\, PhD\, LCSW \nSponsoring organization: American Society for Pain Management Nursing (ASPMN) \nTarget audience: Clinical providers including Physicians\, PAs and NPs \nAbout the webinar: Half of all people with a substance use disorder (SUD) have chronic pain\, and more than a third have a co-occurring psychiatric disorder. The ongoing opioid crisis is a case in point\, where physical and emotional pain fuel opioid addiction and continue to drive countless deaths of despair to this day. Unfortunately\, there are few evidence-based therapies that can simultaneously treat this complex comorbidity. To meet this need\, Mindfulness-Oriented Recovery Enhancement (MORE) was generated through a decade-long treatment development process funded by the National Institutes of Health. Rooted in affective neuroscience\, MORE unites mindfulness training\, cognitive-behavioral therapy\, and principles from positive psychology into an integrative therapy designed to target addiction\, stress\, and pain. This session will detail the theory underlying MORE\, research data demonstrating MORE’s effectiveness\, and unique clinical skills integral to this novel treatment. MORE has been tested in 11 clinical trials funded by more than $40 million in federal research grants. In the largest trial of MORE (250 patients with opioid misuse/OUD)\, MORE decreased opioid misuse by 45% by 9-month follow-up\, more than doubling the effect of standard therapy. MORE also significantly decreased chronic pain\, distress\, depression\, and PTSD. In addition\, MORE has been shown to improve outcomes among people receiving medication assisted treatment. Neuroscience shows that MORE decreases the extent to which the brain is triggered by drug cues\, while increasing brain responses to natural\, healthy rewards. MORE is now being disseminated across the U.S. This dissemination effort is urgently needed\, in light of the opioid settlement monies that are now reaching the states to help alleviate the opioid crisis. \nEducational objectives: \n\nIdentify three cognitive\, affective\, and neurobiological mechanisms implicated in substance use disorders\, affective disorders\, and chronic pain.\nExplain three therapeutic techniques to reduce craving\, regulate addictive behavior\, decrease negative emotions\, and/or manage chronic pain.\nDescribe the clinical outcomes of MORE for chronic pain and opioid misuse.\n\nCredit education information: The Greater Kansas City Chapter of the American Society for Pain Management Nursing® is approved as a provider of continuing nursing education by the Kansas State Board of Nursing. This course offering has been submitted for approval for nursing contact hours applicable for RN\, LPN and LMHT relicensure.
URL:https://www.ctnnortheastnode.org/event/mindfulness-oriented-recovery-enhancement-clinical-outcomes-and-biobehavioral-mechanisms-of-an-evidence-based-therapy-for-chronic-pain-opioid-misuse-and-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230407T120000
DTEND;TZID=America/New_York:20230407T130000
DTSTAMP:20260610T181841
CREATED:20230317T202141Z
LAST-MODIFIED:20230317T202141Z
UID:3211-1680868800-1680872400@www.ctnnortheastnode.org
SUMMARY:Initiating Buprenorphine for Patients Using Fentanyl
DESCRIPTION:Register Now \nPresenter: Brian Hurley\, MD\, MBA\, DFASAM\, FAPA \nCost: No Fee \nTarget audience: Nurses\, Addictions Specialists\, SUD Project Directors\, Managers\, and Facilitators and MOUD (medications for opioid use disorder) providers \nCredit Designations Available: Nursing CE \nWebinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The presenters will review the evidence for and describe low dose buprenorphine initiation of protocols\, high dose buprenorphine initiation of protocols\, approaches to help support patients stop using full agonist opioids for a longer period of time\, and a clinical approach to referring patients to alternative medications for opioid use disorder. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nCompare and contrast low-dose\, high-dose\, standard dose\, and variations for the timing and setting for initiating buprenorphine to treat opioid use disorder involving fentanyl.\nDesign a treatment plan that factors in the risks and benefits of buprenorphine to treat opioid use disorder in consideration of the set\, setting\, and patient’s priorities for their opioid use disorder treatment.\nRecognize the limitations of buprenorphine treatment of opioid use disorder and how to refer to alternative treatments.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/initiating-buprenorphine-for-patients-using-fentanyl/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230411T150000
DTEND;TZID=America/New_York:20230411T160000
DTSTAMP:20260610T181841
CREATED:20230329T185843Z
LAST-MODIFIED:20230329T185843Z
UID:3214-1681225200-1681228800@www.ctnnortheastnode.org
SUMMARY:Xylazine and How it Harms People Who Use Drugs
DESCRIPTION:Register now! \nPresenters: Raagini Jawa\, MD \nCost: No fee \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nDescription: We will review what is known to date on Xylazine\, a CNS depressant\, which has been linked to an increasing number of overdose deaths in the US. This Roundtable will discuss its physiologic effects\, and risk of xylazine harms including overdose and wounds along with suggested clinical best practices for providers and patients. \nThis talk discusses substance use disorder treatment in a post-COVID world. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \nRegister now!
URL:https://www.ctnnortheastnode.org/event/xylazine-and-how-it-harms-people-who-use-drugs/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230419T150000
DTEND;TZID=America/New_York:20230419T160000
DTSTAMP:20260610T181841
CREATED:20230412T162432Z
LAST-MODIFIED:20230412T162432Z
UID:3219-1681916400-1681920000@www.ctnnortheastnode.org
SUMMARY:Opioid Use Disorder and Social Determinants of Health
DESCRIPTION:Presenters: \n  \n\nRachel Talley\, MD\, Assistant Professor of Clinical Psychiatry/Director\, Fellowship in Public and Community Psychiatry\n\n\nJessica Isom\, MD\, Attending Psychiatrist\, Codman Square Health Center/Clinical Instructor\, Yale University/Faculty Lead\, Social Justice and Health Equity Curriculum\n\nSponsor: National Council for Mental Wellbeing–NCMW \nContinuing education information: Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. \nTarget Audience: Interprofessional teams\, family/patients\, nurses\, physicians\, psychiatrists\, psychologists\, social workers\, students/educators \nAbout the webinar: The opioid crisis continues to have a devastating impact on families and communities across the United States. Individuals from marginalized communities\, including Black\, Indigenous and People of Color (BIPOC) communities and individuals who are uninsured or have lower incomes with opioid use disorders (OUD) often experience challenges accessing and sustaining treatment services. Many of these challenges stem from unaddressed social determinants of health factors (housing\, education\, geography etc.) as well as systemic inequities across all care settings. Lack of attention to these factors can lead to inadequate care for OUD and inadequate support for long-term recovery.we will discuss factors that facilitate and hinder engagement in long-term OUD treatment and recovery for BIPOC individuals\, as well as identify strategies for organizations to assess and effectively address opioid use among BIPOC individuals through addressing social determinants of health. \nEducational objectives: \n\nExamine how social determinants of health may impact initiation of and ongoing substance use\nDiscuss factors that facilitate and hinder engagement in long-term treatment and recovery for BIPOC individuals\nIdentify strategies for organizations to assess and address opioid use among BIPOC individuals through addressing social determinants of health\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/opioid-use-disorder-and-social-determinants-of-health/
CATEGORIES:Other Related
END:VEVENT
END:VCALENDAR